Legacy Advisory Services, LLC Novo Nordisk A S Transaction History

Legacy Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$45.38 - $71.7 $790,020 - $1.25 Million	-17,409 Closed	0 $0
Q4 2024 Oct 17, 2025	BUY	$85.0 - $120.04 $472,600 - $667,422	5,560 Added 28.85%	24,835 $2.14 Billion
Q3 2024 Oct 17, 2025	BUY	$119.07 - $145.42 $2.3 Million - $2.8 Million	19,275 New	19,275 $2.3 Billion
Q2 2024 Oct 30, 2025	BUY	$122.71 - $146.91 $2.14 Million - $2.56 Million	17,409 New	17,409 $2.48 Billion
Q2 2024 Oct 17, 2025	BUY	$122.71 - $146.91 $1.6 Million - $1.92 Million	13,039 Added 209.09%	19,275 $2.3 Billion

Q1 2024 Oct 17, 2025	BUY	$102.11 - $135.92 $636,757 - $847,597	6,236 New	6,236 $801 Million

1,693

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Legacy Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Advisory Services, LLC with notifications on news.